Carna Biosciences, Inc. (TYO:4572)
Japan · Delayed Price · Currency is JPY 348.00
-2.00 (-0.57%)
Oct 26, 2026, 3:30 PM JST
Carna Biosciences Market Cap
Carna Biosciences has a market cap or net worth of 8.14 billion as of October 26, 2026. It is the 29,901st most valuable company in the world and the 2,677th biggest in Japan. Its market cap has increased by 99.06% in one year.
Market Cap
8.14B
Enterprise Value
9.02B
Revenue
729.00M
Global Rank
Country Rank
#2,677 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since March 25, 2008, Carna Biosciences's market cap has increased from 4.63B to 8.14B, an increase of 75.89%. That is a compound annual growth rate of 3.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 8.14B | 19.44% |
| Dec 30, 2025 | 6.81B | 18.93% |
| Dec 30, 2024 | 5.73B | -35.99% |
| Dec 29, 2023 | 8.95B | 21.11% |
| Dec 30, 2022 | 7.39B | -49.61% |
| Dec 30, 2021 | 14.67B | -2.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kubota Pharmaceutical Holdings | 9.57B |
| Immuno-Biological Laboratories | 9.34B |
| StemRIM | 9.28B |
| K Pharma,Inc. | 7.90B |
| Kidswell Bio | 7.54B |
| CellSeed | 7.46B |
| J-Pharma | 7.35B |
| OncoTherapy Science | 7.35B |